0B68 Ciric, Bogoljub - Thomas Jefferson University - Thomas Jefferson University
Bogoljub Ciric, PhD

Bogoljub Ciric, PhD

Contact Dr.  Ciric

901 Walnut Street
Suite 400
Philadelphia, PA 19107

(215) 955-9425

Most Recent Peer-reviewed Publications

  1. Tolerogenic dendritic cells produced by lentiviral-mediated CD40- and interleukin-23p19-specific shRNA can ameliorate experimental autoimmune encephalomyelitis by suppressing T helper type 17 cells
  2. Neurotrophin 3 transduction augments remyelinating and immunomodulatory capacity of neural stem cells
  3. Immunotherapy using lipopolysaccharide-stimulated bone marrow-derived dendritic cells to treat experimental autoimmune encephalomyelitis
  4. Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination
  5. Intravenous transfer of apoptotic cell-treated dendritic cells leads to immune tolerance by blocking Th17 cell activity
  6. Immune tolerance induced by intravenous transfer of immature dendritic cells via up-regulating numbers of suppressive IL-10+ IFN-γ+-producing CD4+ T cells
  7. Accelerated and enhanced effect of CCR5-transduced bone marrow neural stem cells on autoimmune encephalomyelitis
  8. CNS-specific therapy for ongoing EAE by silencing IL-17 pathway in astrocytes
  9. IL-10 deficiency blocks the ability of LPS to regulate expression of tolerance-related molecules on dendritic cells
  10. Interleukin-10 plays a crucial role in suppression of experimental autoimmune encephalomyelitis by Bowman-Birk inhibitor
  11. Bowman-Birk inhibitor attenuates experimental autoimmune encephalomyelitis by delaying infiltration of inflammatory cells into the CNS
  12. Generation of immunogenic and tolerogenic clinical-grade dendritic cells
  13. The encephalitogenicity of TH 17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF
  14. Retraction: Immunotherapeutic potential of B7-DC (PD-L2) cross-linking antibody in conferring antitumor immunity (Cancer Research (2004) 1)
  15. Neutralization of IL-9 ameliorates experimental autoimmune encephalomyelitis by decreasing the effector T cell population
  16. Evaluation of bone marrow- and brain-derived neural stem cells in therapy of central nervous system autoimmunity
  17. Expression of 3G11 epitope defines subpopulations of regulatory T cells with different suppressive potency
  18. Targeting ganglioside epitope 3G11 on the surface of CD4+ T cells suppresses EAE by altering the Treg/Th17 cell balance
  19. B7-DC/PD-L2 cross-linking induces NF-κB-dependent protection of dendritic cells from cell death (The Journal of Immunology (2007) 178, (1426-1432))
  20. Naturally occurring human IgM antibody that binds B7-DC and potentiates T cell stimulation by dendritic cells (The Journal of Immunology (2003) 170, (1830-1838))
0